curosurf
(poractant alfa)Chiesi USA, Inc.
Usage: CUROSURF® (poractant alfa) is indicated for the rescue treatment of Respiratory Distress Syndrome (RDS) in premature infants, helping to reduce mortality and the occurrence of pneumothoraces associated with the condition.